Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer.
Li J, Gonzalez-Angulo AM, Allen PK, Yu TK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Bondy ML, Yang W, Willey JS, Cristofanilli M, Valero V, Buchholz TA.
Li J, et al. Among authors: allen pk.
Oncologist. 2011;16(12):1675-83. doi: 10.1634/theoncologist.2011-0196. Epub 2011 Dec 6.
Oncologist. 2011.
PMID: 22147002
Free PMC article.